Quantcast

John Craighead, PhD, Managing Director of BIO’s Investor Relations operation, has presented his outlook for biotechnology stocks, investor perceptions, mergers & acquisitions activity and IPOs for the coming year. Click here for a 25-slide PDF of his presentation at Bio Europe Spring conference March 14, 2011.

1 Trackback or Pingback

Leave a Reply

Your email address will not be published. Required fields are marked *

*